CCM
ZBH icon

Cai Capital Management’s Zimmer Biomet ZBH Stock Holding History

Cai Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,332
Closed -$897K – 258
2013
Q2 		$897K Buy
+12,332
New +$922K 0.52% 71

Other funds holding ZBH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cai Capital Management's ZBH Position: Q3 2013 in Review

Cai Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2013, closing a stake of 12,332 shares — an estimated $897K sold.

Cai Capital Management first reported a position in ZBH in Q2 2013 and held it in 1 quarter. The position peaked at $897K in Q2 2013. 650 funds tracked by Wall St. Rank hold ZBH as of Q3 2013.

  • Cai Capital Management reported no remaining Zimmer Biomet position as of Q3 2013 after selling out during the quarter.
  • Cai Capital Management sold 12,332 Zimmer Biomet shares in Q3 2013, an estimated $897K.
  • Cai Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 1 quarter.
  • Cai Capital Management's Zimmer Biomet position peaked at $897K in Q2 2013.
  • 650 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2013.

Based on Cai Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.